LIBST seminar

November 16, 2018

12:50

Louvain-la-Neuve

Seminar Room LIBST

Dirk DEALEMANS (KULeuven, Belgium): Discovery and validation of nuclear export inhibitors as novel cancer therapeutics and target deconvolution using CRISPR mutagenesis scanning